Revolution Medicines vs Waters
Revolution Medicines (RVMD), health care, and Waters (WAT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Waters is worth $88.4B on the stock market and Revolution Medicines $35.2B: Waters is valued at 2.5 times as much. Over the past year Revolution Medicines's share price has moved +136% and Waters's +20.4%.
Key facts
- Revolution Medicines market value
- $35.2B
- Waters market value
- $88.4B
- Waters P/E
- 190
- Revolution Medicines revenue
- $0FY to 2025-12-31
- Waters revenue
- $3.2BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Revolution Medicines | Waters |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $35.2Blower | $88.4Bhigher |
| Revenue | $0lower | $3.2Bhigher |
| Earnings | -$1.1Blower | $642.6Mhigher |
| Employees | 883lower | 15,000higher |
| Total assets | $2.4Blower | $5.1Bhigher |
| Valuation | ||
| P/E | — | 190 |
| P/S | — | 27.9 |
| P/B | 14.7higher | 2.9lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | — | 25.4% |
| Balance sheet | ||
| Net assets | $1.6Blower | $2.6Bhigher |
| Total liabilities | $723.2Mlower | $2.5Bhigher |
| Total debt | — | $1.4B |
| Cash on hand | $383.7Mlower | $587.8Mhigher |
| Price change | ||
| Today | -2.50%lower | -0.80%higher |
| 1 year | +136%higher | +20.4%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Brandon Haley0.6% / 0.7%
Revolution Medicines only (4)
- Andrew Spokes14.4%
- Julian and Felix Baker10.7%
- Stanley Druckenmiller1.7%
- Louis Bacon0.5%
Waters only (10)
- Terry Smith7.7%
- Andreas Halvorsen1.8%
- Steven Romick1.4%
- Nicolai Tangen (founder)0.8%
- Matthew McLennan0.7%
- Jensen team0.5%
- Steve Cohen0.3%
- Israel Englander0.2%
- David Shaw (founder)0.2%
- Bill Nygren<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Revolution Medicines / Waters). Who owns RVMD · Who owns WAT
More on Revolution Medicines
Further comparisons
Revolution Medicines against its closest peers
Waters against its closest peers
Learn
Questions and answers
Which is bigger, Revolution Medicines or Waters?
By market value, Waters is the larger: $88.4B against $35.2B for Revolution Medicines. By revenue in its latest fiscal year, Waters is the larger: $3.2B against $0 for Revolution Medicines.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Revolution Medicines and Waters?
In their latest 13F filings, Brandon Haley holds both.
Cite this page
Funkfolio, “Revolution Medicines vs Waters”, data as of 18 November 2026. https://funkfolio.com/compare/rvmd-vs-wat
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.